This study is not yet accepting patients

Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia (BG-Aphasia-02)

a study on Aphasia Amyotropic Lateral Sclerosis (ALS) Stroke

Summary

Eligibility
for people ages 18-80 (full criteria)
Location
at Sacramento, California
Dates
study started
study ends around
Principal Investigator
by David M Brandman, M.D., Ph.D.

Description

Summary

In this study, the investigators aim to continue the development of a brain-computer interface (BCI) to help restore speech for stroke survivors with agrammatic aphasia, a language disorder that affects the ability to speak.

Official Title

Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia

Details

One in four adults will have a stroke in their lifetime. When the blood flow to the brain is blocked or reduced, brain cells get deprived of oxygen. This might impact language areas in the brain and lead to aphasia.

The goal of this project is to advance the methods by which people with aphasia can help develop and by using an intracortical brain-computer interface (iBCI) restore communication that may serve as a rehabilitation device.

Keywords

Aphasia, ALS, Stroke, brain computer interface, BCI, iBCI, BrainGate Neural Interface System

Eligibility

You can join if…

Open to people ages 18-80

You CAN'T join if...

  • Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
  • Chronic oral or intravenous steroids or immunosuppressive therapy
  • Other serious disease or disorder that could seriously affect ability to participate in the study

(There are additional exclusion criteria)

Location

  • University of California, Davis
    Sacramento California 95817 United States

Lead Scientist at UC Davis

  • David M Brandman, M.D., Ph.D.
    Associate Professor, Med: Neurological Surgery, School of Medicine. Authored (or co-authored) 46 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Leigh R. Hochberg, MD, PhD.
ID
NCT07918768
Study Type
Interventional
Participants
Expecting 2 study participants
Last Updated